Completed OBSERVATIONAL NCT05050981

Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake Inhibitor on Cognition, Sexual Function and Quality of Life

Comparison of Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake in Postmenopausal Women

Sponsor: Faculdade de Medicina do ABC

Conditions Menopause

Interventions Hormone replacement therapy Selective serotonin reuptake inhibitors

Updated 5 times since 2021 Last updated: Sep 7, 2022 Started: Mar 1, 2021 Primary completion: Feb 28, 2022 Completion: Feb 28, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Menopause, this trial is completed. The trial is conducted by Faculdade de Medicina do ABC and has accumulated 5 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Feb 2022 — Sep 2022 [monthly]

Recruiting
Oct 2021 — Feb 2022 [monthly]

Recruiting

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Faculdade de Medicina do ABC

Data source: Faculdade de Medicina do ABC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Bernardo do Campo, Brazil